Gland Pharma Peer Comparison
NSE: GLAND | BSE: 543245
₹2,885.80
As on 31-Aug-2026IST
Market cap
₹47,647 Cr
Revenue (TTM)
₹6,725 Cr
P/E Ratio
42.2
P/B Ratio
4.5
Div. Yield
0.7 %
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
47,647 | 8,072 | 1,075 | 52 | 33 |
Revenue (₹ Cr) |
6,725 | 7,229 | 287 | 21 | 56 |
Net Profit (₹ Cr) |
1,128.79 | 210.43 | 28.67 | 3.24 | -1.45 |
Net Margin (%) |
16.02 | 2.88 | 9.68 | 15.18 | -2.56 |
RoE (%) |
11.51 | 11.02 | 9.14 | 19.12 | -4.88 |
Price to Earnings |
42.21 | 38.35 | 34.80 | 16.08 | -- |
Price-To-Book |
4.48 | 4.04 | 4.25 | 2.80 | 1.19 |
Income Statement (₹ Cr)
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Operating Revenue
|
6,430.65 | 6,892.47 | 239.11 | 16.80 | 53.52 |
|
Total Income
|
6,746.98 | 6,963.79 | 242.45 | 16.93 | 53.64 |
|
Total Expenditure
|
4,801.11 | 6,268.09 | 196.46 | 14.47 | 47.10 |
|
EBITDA
|
1,629.54 | 624.38 | 42.65 | 2.34 | 6.42 |
|
Depreciation
|
423.67 | 282.87 | 15.02 | 0.81 | 4.25 |
|
EBIT
|
1,205.88 | 341.51 | 27.63 | 1.53 | 2.16 |
|
Interest
|
33.28 | 137.50 | 6.17 | 0.61 | 3.90 |
|
Other Income
|
316.33 | 71.32 | 3.34 | 0.12 | 0.12 |
|
Exceptional Items
|
-24.35 | -- | 7.03 | -- | -- |
|
Profit before Tax
|
1,464.58 | 275.33 | 31.83 | 1.04 | -1.62 |
|
Provision for Tax
|
437.26 | 55.72 | 6.45 | 0.29 | -0.15 |
|
Profit after Tax
|
1,027.32 | 219.61 | 25.38 | 0.75 | -1.46 |
Liabilities (₹ Cr)
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
10,357.95 | 1,975.36 | 208.54 | 13.78 | 30.75 |
|
Minority Interest
|
-- | -0.71 | 0.16 | 0.00 | -- |
|
Non-Current Liabilities
|
482.17 | 1,225.00 | 12.82 | -0.07 | 21.97 |
|
Current Liabilities
|
1,608.40 | 763.90 | 56.70 | 8.87 | 31.83 |
|
Total Liabilities
|
12,448.52 | 4,084.80 | 284.67 | 23.05 | 84.58 |
Assets (₹ Cr)
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
4,921.74 | 1,820.29 | 91.16 | 5.39 | 21.59 |
|
Current Assets
|
7,526.79 | 2,143.26 | 187.06 | 17.19 | 62.96 |
|
Total Assets
|
12,448.52 | 4,084.80 | 284.67 | 23.05 | 84.58 |
|
Total Debt*
|
243.36 | 0.00 | 11.37 | 5.07 | 12.26 |
|
Net Current Assets
|
5,918.38 | 1,379.36 | 130.35 | 8.32 | 31.13 |
|
Contingent Liabilities
|
10.12 | 14.06 | -- | 0.42 | 0.10 |
Cashflow (₹ Cr)
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,031.39 | 495.58 | 43.83 | -0.01 | 17.07 |
|
Cash Flow from Investing Activities
|
137.73 | -127.72 | -29.24 | -0.04 | -11.61 |
|
Cash from Financing Activities
|
-416.97 | -255.51 | 110.64 | 0.19 | -5.93 |
|
Net Cash Inflow / Outflow
|
752.14 | 112.36 | 125.23 | 0.14 | -0.47 |
Ratios
Profitability Ratios
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
ROCE (%)
|
14.96 | 22.22 | 24.97 | 9.13 | 5.09 |
|
ROE (%)
|
10.56 | 11.93 | 21.40 | 5.59 | -4.93 |
|
ROA (%)
|
8.70 | 6.00 | 12.64 | 3.42 | -1.79 |
|
EBIT Margin (%)
|
30.26 | 10.09 | 19.23 | 14.64 | 12.22 |
|
Net Margin (%)
|
15.23 | 3.15 | 10.47 | 4.43 | -2.73 |
|
Cash Profit Margin (%)
|
22.56 | 7.19 | 16.89 | 9.27 | 5.22 |
Growth Ratios
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
14.50 | 12.33 | 23.53 | -23.76 | 4.55 |
|
EBIT Growth (%)
|
31.25 | 26.01 | 76.27 | -59.17 | 23.91 |
|
Net Profit Growth (%)
|
47.07 | 46.18 | 41.44 | -77.67 | -229.03 |
|
EPS Growth (%)
|
47.07 | 45.68 | -35.33 | -77.67 | -229.03 |
|
Book Value Growth (%)
|
12.70 | 14.76 | 569.07 | 5.75 | -4.81 |
Valuation Ratios
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Price / Earnings
|
27.22 | 45.79 | 76.82 | 29.91 | 0.00 |
|
Price / Book Value
|
2.71 | 5.11 | 11.83 | 1.63 | 1.38 |
|
Dividend Yield (%)
|
1.18 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
12.77 | 13.79 | 50.94 | 10.73 | 7.98 |
|
Market Cap (₹ Cr)
|
27,964.97 | 10,057.49 | 2,440.49 | 22.43 | 40.13 |
Solvency Ratios
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.02 | 0.00 | 0.06 | 0.37 | 0.40 |
|
Short term debt to equity ratio
|
-- | -- | -- | 0.33 | 0.40 |
|
Current Ratio
|
4.68 | 2.81 | 3.30 | 1.94 | 1.98 |
|
Quick Ratio
|
3.60 | 1.00 | 2.97 | 1.15 | 0.61 |
|
Interest Coverage
|
45.01 | 3.00 | 6.16 | 2.71 | 0.59 |
Operating Efficiency Ratios
| Gland Pharma | Medplus Health | Laxmi Dental | Shree Pacetronix | Centenial Surgical | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
29.41 | 0.39 | 15.34 | 39.46 | 34.38 |
|
Asset Turnover
|
0.54 | 1.91 | 1.19 | 0.77 | 0.65 |
|
Receivable days
|
96.72 | 1.05 | 47.00 | 122.59 | 126.86 |
|
Inventory Days
|
97.32 | 71.25 | 33.10 | 138.71 | 293.26 |
|
Payable days
|
134.60 | 21.75 | 152.61 | 36.89 | 178.88 |
|
Cash Conversion Cycle
|
59.43 | 50.55 | -72.51 | 224.42 | 241.25 |